Autonomix Medical, Common Stock Current Valuation
| AMIX Stock | 3.35 0.18 5.10% |
Valuation analysis of Autonomix Medical, Common helps investors to measure Autonomix Medical,'s intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value Over EBITDA is likely to rise to -3.5 in 2024. Enterprise Value Multiple is likely to rise to -3.5 in 2024. Fundamental drivers impacting Autonomix Medical,'s valuation include:
Price Book 1.9556 | Enterprise Value 2.2 M |
Overvalued
Today
Please note that Autonomix Medical,'s price fluctuation is abnormally volatile at this time. Calculation of the real value of Autonomix Medical, Common is based on 3 months time horizon. Increasing Autonomix Medical,'s time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Autonomix Medical, is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Autonomix Stock. However, Autonomix Medical,'s intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.35 | Real 2.31 | Target 1.4 | Hype 2.94 | Naive 2.49 |
The intrinsic value of Autonomix Medical,'s stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Autonomix Medical,'s stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Autonomix Medical, Common helps investors to forecast how Autonomix stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Autonomix Medical, more accurately as focusing exclusively on Autonomix Medical,'s fundamentals will not take into account other important factors: Autonomix Medical, Common Company Current Valuation Analysis
Autonomix Medical,'s Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Autonomix Medical, Current Valuation | 2.17 M |
Most of Autonomix Medical,'s fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Autonomix Medical, Common is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Autonomix Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Autonomix Medical, is extremely important. It helps to project a fair market value of Autonomix Stock properly, considering its historical fundamentals such as Current Valuation. Since Autonomix Medical,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Autonomix Medical,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Autonomix Medical,'s interrelated accounts and indicators.
Click cells to compare fundamentals
Autonomix Current Valuation Historical Pattern
Today, most investors in Autonomix Medical, Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Autonomix Medical,'s growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Autonomix Medical, current valuation as a starting point in their analysis.
Autonomix Medical, Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Autonomix Medical, Common has a Current Valuation of 2.17 M. This is 99.98% lower than that of the Health Care Equipment & Supplies sector and 99.98% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.99% higher than that of the company.
Autonomix Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Autonomix Medical,'s direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Autonomix Medical, could also be used in its relative valuation, which is a method of valuing Autonomix Medical, by comparing valuation metrics of similar companies.Autonomix Medical, is currently under evaluation in current valuation category among its peers.
Autonomix Fundamentals
| Return On Equity | -270.17 | ||||
| Return On Asset | -1.76 | ||||
| Current Valuation | 2.17 M | ||||
| Shares Outstanding | 1.77 M | ||||
| Shares Owned By Insiders | 27.20 % | ||||
| Shares Owned By Institutions | 8.67 % | ||||
| Number Of Shares Shorted | 36.62 K | ||||
| Price To Book | 1.96 X | ||||
| EBITDA | (15.27 M) | ||||
| Net Income | (15.43 M) | ||||
| Total Debt | 1 M | ||||
| Book Value Per Share | 3.21 X | ||||
| Cash Flow From Operations | (6.65 M) | ||||
| Short Ratio | 0.06 X | ||||
| Earnings Per Share | (19.74) X | ||||
| Target Price | 28.0 | ||||
| Market Capitalization | 6.24 M | ||||
| Total Asset | 9.41 M | ||||
| Retained Earnings | (38.97 M) | ||||
| Working Capital | 8.61 M | ||||
| Net Asset | 9.41 M |
About Autonomix Medical, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Autonomix Medical, Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Autonomix Medical, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Autonomix Medical, Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Autonomix Stock Analysis
When running Autonomix Medical,'s price analysis, check to measure Autonomix Medical,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Autonomix Medical, is operating at the current time. Most of Autonomix Medical,'s value examination focuses on studying past and present price action to predict the probability of Autonomix Medical,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Autonomix Medical,'s price. Additionally, you may evaluate how the addition of Autonomix Medical, to your portfolios can decrease your overall portfolio volatility.